Genetic Disorders and the Fetus. Группа авторов
Blut [Correlation of cotinine level in amniotic fluid, umbilical artery blood and maternal blood]. Geburtshilfe Frauenheilkd 1995; 55:156.
304 304. Ramsay SL, Maire I, Bindloss C, et al. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases. Mol Genet Metab 2004; 83:231.
305 305. Nicholls TM, Hahnel R, Wilkinson SP. Organic acids in amniotic fluid. Clin Chim Acta 1978; 84:11.
306 306. Baggot PJ, Eliseo AJ, DeNicola NG, et al. Organic acid concentrations in amniotic fluid found in normal and Down syndrome pregnancies. Fetal Diagn Ther 2008; 23:245.
307 307. Mattison DR. Amniotic fluid osmolality. Obstet Gynecol 1970; 36:420.
308 308. Wandzilak TR, Hanson FW, Williams HE. The quantitation of oxalate in amniotic fluid by ion chromatography. Clin Chim Acta 1989; 185:131.
309 309. Johnell HE, Nilsson BA. Oxygen tension, acid‐base status and electrolytes in human amniotic fluid. Acta Obstet Gynecol Scand 1971; 50:183.
310 310. Seppala M, Aho I, Tissari A, et al. Radioimmunoassay of oxytocin in amniotic fluid, fetal urine, and meconium during late pregnancy and delivery. Am J Obstet Gynecol 1972; 114:788.
311 311. Westergaard JG, Chemnitz J, Teisner B, et al. Pregnancy‐associated plasma protein A: a possible marker in the classification and prenatal diagnosis of Cornelia de Lange syndrome. Prenat Diagn 1983; 3:225.
312 312. Schlievert P, Johnson W, Galask RP. Bacterial growth inhibition by amniotic fluid. V. Phosphate‐to‐zinc ratio as a predictor of bacterial growth‐inhibitory activity. Am J Obstet Gynecol 1976; 125:899.
313 313. Mihailovic M, Cvetkovic M, Ljubic A, et al. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid. Biol Trace Elem Res 2000; 73:47.
314 314. Condroelli S, Cosmi EV, Scarpelli EM. Extrapulmonary source of amniotic fluid phospholipids. Am J Obstet Gynecol 1974; 118:842.
315 315. Moon TC, Lee JH, Lee SH, et al. Detection and characterization of a type IIA secretory phospholipase A2 inhibitory protein in human amniotic fluid. Biol Pharm Bull 2000; 23:1163.
316 316. Foster WG, Chan S, Platt L, Hughes CL, Jr. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 2002; 129:199.
317 317. Makrydimas G, Sotiriadis A, Savvidou MD, et al. Physiological distribution of placental growth factor and soluble Flt‐1 in early pregnancy. Prenat Diagn 2008; 28:175.
318 318. Vesce F, Scapoli C, Giovannini G, et al. Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies. Obstet Gynecol 2001; 97:404.
319 319. Verkleij‐Hagoort AC, Ursem NT, Hop WC, et al. Complex congenital malformations and the impact of the plasminogen activator system and beta‐hCG in amniotic fluid. Eur J Obstet Gynecol Reprod Biol 2007; 135:47.
320 320. Prado VF, Reis DD, Pena SD. Biochemical and immunochemical identification of the fetal polypeptides of human amniotic fluid during the second trimester of pregnancy. Braz J Med Biol Res 1990; 23:121.
321 321. Phillips LL, Davidson EC, Jr. Procoagulant properties of amniotic fluid. Am J Obstet Gynecol 1972; 113: 911.
322 322. Kauppila S, Tekay A, Risteli L, et al. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta. Eur J Clin Invest 1998; 28:831.
323 323. Ben‐Jonathan N, Munsick RA. Dopamine and prolactin in human pregnancy. J Clin Endocrinol Metab 1980; 51:1019.
324 324. Singh EJ, Zuspan FP. Content of amniotic fluid prostaglandins in normal, diabetic, and drug‐abuse human pregnancy. Am J Obstet Gynecol 1974; 118: 358.
325 325. Graca G, Duarte IF, Goodfellow BJ, et al. Potential of NMR spectroscopy for the study of human amniotic fluid. Anal Chem 2007; 79:8367.
326 326. Kaufman S. Protein‐bound iodine (pbi) in human amniotic fluid. J Pediatr 1966; 68:990.
327 327. Uszynski M, Zekanowska E, Kotzbach M, et al. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study. J Perinat Med 2006; 34:289.
328 328. Chi L, Wolff JJ, Laremore TN, et al. Structural analysis of bikunin glycosaminoglycan. J Am Chem Soc 2008; 130:2617.
329 329. Porre S, Heinonen S, Mantyjarvi R, et al. Psoriasin, a calcium‐binding protein with chemotactic properties is present in the third trimester amniotic fluid. Mol Hum Reprod 2005; 11:87.
330 330. Franks RC, Hayashi RH. Maternal and fetal renin activity and renin and big renin concentrations in second‐trimester pregnancy. Am J Obstet Gynecol 1979; 134:20.
331 331. Cederqvist LL, Zervoudakis IA, Ewool LC, et al. Prenatal diagnosis of congenital rubella. Br Med J 1977; 1:615.
332 332. Teichler‐Zallen D, Doherty RA. Amniotic fluid secretor typing: validation for use in prenatal prediction of myotonic dystrophy. Clin Genet 1980; 18:257.
333 333. Aula N, Aula P. Prenatal diagnosis of free sialic acid storage disorders (SASD). Prenat Diagn 2006; 26:655.
334 334. Cox LW, Chalmers TA. The transfer of sodium to the amniotic fluid in normal and abnormal cases, determined by Na24 tracer methods. J Obstet Gynaecol Br Emp 1953; 60:222.
335 335. Tham A, Wetterberg L, Sara VR. Immunoreactive somatomedin B in the human foetus and in women during pregnancy. Acta Endocrinol (Copenh) 1987; 115:218.
336 336. Niswander KR. Spectrophotometric analysis of amniotic fluid in early gestation. Am J Obstet Gynecol 1970; 108:1296.
337 337. Fortunato SJ, Menon R, Lombardi SJ. Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes. Obstet Gynecol 1999; 94:435.
338 338. Frosolono MF, Roux JF. Surface‐active material in human amniotic fluid. Am J Obstet Gynecol 1978; 130: 562.
339 339. Muller‐Tyl E, Lempert J, Steinbereithner K, et al. Surface properties of the amniotic fluid in normal pregnancy. Am J Obstet Gynecol 1975; 122:295.
340 340. Belisle S, Fencl MM, Tulchinsky D. Amniotic fluid testosterone and follicle‐stimulating hormone in the determination of fetal sex. Am J Obstet Gynecol 1977; 128:514.
341 341. Tersenov OA, Mikhaleva IV, Usol'tseva VA, et al. O svertyvaiushchei aktivnosti okoloplodnykh vod [Coagulative activity of the amniotic fluid]. Akush Ginekol (Mosk) 1989: 43.
342 342. Sainio S, Javela K, Kekomaki R, et al. Thrombopoietin levels in cord blood plasma and amniotic fluid in fetuses with alloimmune thrombocytopenia and healthy controls. Br J Haematol 2000; 109:330.
343 343. Hall GS, Carr MJ, Cummings E, et al. Aluminum, barium, silicon, and strontium in amniotic fluid by emission spectrometry. Clin Chem 1983; 29:1318.
344 344. Hufner M, Grussendorf M, Lorenz U, et al. 3,3′,5′‐Triiodothyronine (reverse T3) in amniotic fluid and cord serum. Eur J Pediatr 1977; 125:213.
345 345. Stefanovic V, Loukovaara M. Amniotic fluid cardiac troponin T in pathological pregnancies with evidence of chronic fetal hypoxia. Croat Med J 2005; 46: 801.
346 346. Menon R, Thorsen P, Vogel I, et al. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)‐alpha and soluble TNF receptors in spontaneous preterm birth. Am J Obstet Gynecol 2008; 198: 533 e1.
347 347. Park CW, Park JS, Shim SS, et al. An elevated maternal plasma, but not amniotic fluid, soluble fms‐like tyrosine kinase‐1 (sFlt‐1) at the time of mid‐trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol 2005; 193:984.
348 348. Enlander D. Amniotic fluid indicators of fetal maturity. Obstet Gynecol 1972; 40:605.
349 349. Kobayashi H, Suzuki K, Sugino D, et al. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol 1999; 180:141.
350 350. Wallingford JC, Milunsky A, Underwood BA. Vitamin